Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages - Wikidata - awgldk - TriplyDB

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

http://www.wikidata.org/entity/Q36713193

about

Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue Checkpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous System The crustacean central nervous system in focus: subacute neurodegeneration induces a specific innate immune response Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease Enhanced Aβ(1-40) production in endothelial cells stimulated with fibrillar Aβ(1-42)How to get from here to there: macrophage recruitment in Alzheimer's disease Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes.Nuclear receptors as therapeutic targets for Alzheimer's disease Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils.High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence.Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia Preparing synthetic Aβ in different aggregation states.Medical bioremediation of age-related diseases.Immune activation in brain aging and neurodegeneration: too much or too little?Role of endosomes and lysosomes in human disease.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'.Modulation of inflammation in transgenic models of Alzheimer's disease Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.Staging anti-inflammatory therapy in Alzheimer's disease.Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.Microglia display modest phagocytic capacity for extracellular tau oligomers.Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection.Amyloid-β increases metallo- and cysteine protease activities in human macrophages.A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.AA-Amyloid is cleared by endogenous immunological mechanisms.Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

P2860

Q27303708-E114E6D6-5D41-4E9C-87E0-4EF634E1396A Q27679935-1E8EEB36-E73D-4542-B0F0-E6F5F16B713D Q28066906-4C8E0F4B-76ED-4300-8C23-25E7A477697F Q28535309-DF5469C9-0C84-4057-9016-12F266AC7EF7 Q28548344-C86BF070-B746-4AA1-BEFB-1F0C5A2D3CCC Q33682529-2DCEFF76-8382-4D30-8838-6DC4A3F193CD Q34014237-CE419998-0FDE-465C-AE2A-79DE61A4CEBD Q34344688-8B06209B-FF98-4436-8C8D-E33BE4C01EEC Q34375724-A5075E4F-B62F-4761-824B-9ABDCF29380B Q34419295-E1B62FFB-91DA-47AD-8F35-7611531CDC83 Q34625636-A7BA397F-D95F-4A88-A989-D0CDBF7A9DD5 Q34912085-A1EE81E4-60ED-4B17-BE77-D27F867B89C7 Q34977292-2CB7E280-C3BD-447C-BDA4-C211120A1B78 Q35165186-C379CFDC-9BEE-45D7-8B53-076B8CFBAD82 Q35723681-B8A9E04B-4B22-4C74-A2F9-FB68C52F5570 Q36629269-A7990FAC-D04B-4D70-A111-91D43A390EC9 Q36952064-C8F01B21-709B-4298-88AA-52E0EE5BE48C Q37119634-19450BBB-AAA7-4246-B7AE-2C872E37C413 Q37172423-123133C0-351E-48B4-B730-0CE2316DD2E3 Q37617634-881C235B-582E-439F-93BC-1F9B2B86DEB0 Q37718121-04985B12-779A-4F5A-B187-F18A73819465 Q37982377-F043058D-CF58-41F7-B041-10941B8056D8 Q38021993-0AB45068-DE02-491A-92B1-22D411C8D160 Q38046114-19FD01D4-344E-4DFE-96E0-E091EB6809F4 Q38184606-DB79A564-A103-468B-8D24-087DDF0D9B9B Q39135845-61DD605C-7DDD-40BA-97CD-AC865270B8F8 Q39497033-E8926CEE-C2E1-44B8-8D1A-7DC1BA7B3560 Q41179524-11B0B80A-A8BE-4B66-A40D-680F4313AD02 Q42002681-E255F821-C19A-4C7E-A72F-F9E83C695FC7 Q42119910-24F4D201-CA46-444E-9A06-F2854B3D8187 Q42380907-786CA1B5-BC95-4B89-94E1-1A00F7F62569 Q42911754-3292ED25-6B9F-434F-8F21-235FD908A5C8 Q44197929-E6CD8240-1DAD-4A9A-BA66-84A551C983BA Q44231131-67A72A10-7705-4B7A-978B-139A2C8E6788 Q47874558-8002153F-0518-4FB9-A415-DFD5DE9207D1 Q53150777-6C942BD9-1709-4775-8B08-1A5039972EB6 Q57967107-0D215A10-E47B-425B-BEC3-DC5248DF05B0

P2860

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

http://www.wikidata.org/entity/Q36713193

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@ast

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@en

type

label

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@ast

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@en

prefLabel

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@ast

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@en

P1433

Q36713193-F3E67917-E148-4963-BE68-E463656ACAC3

P1476

Q36713193-F1790CE9-1603-4F40-BD85-9DC8CD3521D3

P2093

Q36713193-1070D59B-5642-4B09-A59D-E0A40DB8CC02

Q36713193-68915913-BCDE-4CC6-B654-DC9B9DE59B3A

Q36713193-84E3FB17-7B4A-4FCD-9585-8898823008C0

Q36713193-8C5E14AC-9B89-4F66-B709-951396882C89

Q36713193-B88D13F8-4BDA-4207-90E8-28F6B48C5634

Q36713193-DF41B5BD-867E-4DEA-BE39-01A792392D35

Q36713193-F82CEF42-20BF-457F-8F56-C742A80F700F

P2860

Q36713193-080E554A-5081-4EFC-B1B7-F9101255DB18

Q36713193-0CF63F8D-EE45-47C5-BD79-A87E95C8A593

Q36713193-1183A611-42CA-4C37-9144-39391B4A9E08

Q36713193-1B73E175-4ACD-4808-89FF-6CF9C717361E

Q36713193-258085D4-E646-4CA2-89CB-D9A9FFBDC761

Q36713193-2A28BE5F-150A-437E-A6FE-DD7665609F51

Q36713193-3436F490-1905-4580-A79B-C426F54F5D19

Q36713193-3AF1C89D-5357-4545-9E06-60CAD2FA6FD2

Q36713193-3DC182BC-3BAD-4A9D-AE04-F9134C37A30A

Q36713193-4246F90E-67EC-4A1F-93E0-098A98265F49

P304

Q36713193-7F18ADB6-C6F8-481E-AAB2-24D155F34192

P31

Q36713193-DE90B3AE-2A6D-4CD2-9EB6-18EDE90C1351

P356

Q36713193-D981A069-EF09-40B5-91BE-B278F0539A17

P433

Q36713193-7B225EA6-3A26-48D5-9D6B-BBB45A026672

P478

Q36713193-83CC2867-3BB7-4C14-9554-EFEEAE68B1E9

P577

Q36713193-E0DF91C0-F5A6-4A0A-90D3-7304A2E41FF0

P5875

Q36713193-01498210-38F7-4921-9DCC-09E44A59D16C

P698

Q36713193-F1739D4A-1D4E-45D8-8823-C196796A7A8F

P921

Q36713193-074FE157-4598-4CE6-B785-ECF28272FCE9

Q36713193-A7E99649-4F1D-4703-88A1-20EA21C76147

P932

Q36713193-039ED142-A0CD-4B87-9224-549E30B0E658

P356

J.NEUROBIOLAGING.2006.12.001

P1433

Neurobiology of Aging

P1476

Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages

@en

P2093

Amitabha Majumdar

http://www.w3.org/2001/XMLSchema#string

Frederick R Maxfield

http://www.w3.org/2001/XMLSchema#string

Georgia Dolios

http://www.w3.org/2001/XMLSchema#string

Haeyong Chung

http://www.w3.org/2001/XMLSchema#string

Nikiya Asamoah

http://www.w3.org/2001/XMLSchema#string

Peter Lobel

http://www.w3.org/2001/XMLSchema#string

Rong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Mannose 6-phosphate receptors: new twists in the tale

Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

ATP mediates rapid microglial response to local brain injury in vivo

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

The human brain mannose 6-phosphate glycoproteome: a complex mixture composed of multiple isoforms of many soluble lysosomal proteins.

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.

P304

707-715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2006.12.001

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247227854

http://www.w3.org/2001/XMLSchema#string

P698

17222479

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2424018

http://www.w3.org/2001/XMLSchema#string